The opioid crisis has grown to affect pregnant women and infants across the United States,
as evidenced by rising rates of opioid use disorder among pregnant women and neonatal …

Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

Objective: Neonatal abstinence syndrome (NAS), a postnatal opioid withdrawal syndrome,
increased threefold from 2000 to 2009. Since 2009, opioid pain reliever prescriptions and …

Enteral nutrition (EN) is a valuable clinical intervention for patients of all ages in a variety of
care settings. Along with its many outcome benefits come the potential for adverse effects …

Background The incidence of the neonatal abstinence syndrome, a drug-withdrawal
syndrome that most commonly occurs after in utero exposure to opioids, is known to have …

Breastfeeding and human milk are the normative standards for infant feeding and nutrition.
Given the documented short-and long-term medical and neurodevelopmental advantages of …

Maternal use of certain drugs during pregnancy can result in transient neonatal signs
consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting …

Many mothers are inappropriately advised to discontinue breastfeeding or avoid taking
essential medications because of fears of adverse effects on their infants. This cautious …

In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …

Purpose The American Society of Addiction Medicine (ASAM) developed the National
Practice Guideline for the Treatment of Opioid Use Disorder (the Practice Guideline) to …